Senate probes why Ozempic, Wegovy US prices are double other countries

Their commercials are ubiquitous, their clients include the rich and famous, and the results can be life changing. But Novo Nordisk, which creates the diabetes drug Ozempic and the weight loss medication Wegovy, is under fire from the Senate HELP committee for its prices in the United States, which are significantly higher than other countries. 

Sen. Bernie Sanders, I-VT: “What we are dealing with today is not just an issue of economics. It is not just an issue of corporate greed. It is a profound moral issue. “

Here are the numbers: 

In the United States Ozempic sells for $969. It costs $155 in Canada, $122 in Denmark, $71 in France, and $59 in Germany. 

Wegovy costs $1,349 in America, $265 in Canada, $186 in Denmark, $137 in Germany and $82 in the UK. 

Sanders pointed out two facts in particular as he pressured Novo Nordisk’s CEO to lower costs – 

1) 72% of the company’s $50 billion in sales on those products has come from the United States. 

2) Senator Sanders says he’s spoken with other drug manufacturers who say they could make and sell a generic to Americans for less than $100 per month. 

Sen. Bernie Sanders, I-VT: “The vast majority of the American people are sick and tired of paying outrageously high prices for prescription drugs.”

Novo Nordisk CEO Lars Jorgensen said many Americans pay $25 out of pocket if Ozempic is covered by their insurance, Sanders countered that’s just a pass through to higher insurance premiums. Sanders kept pressing on the difference in prices from country to country, but Jorgensen blamed the system or tried to explain why the prices aren’t really what they appear. 

Sen. Bernie Sanders, I-VT: “If you don’t act, 40,000 people a year could die. Is this acceptable to you? Any prospects of patients not getting access to the medicine they need?” 

Lars Fruergaard Jørgensen: “Any prospect of patients not getting access to the medicine they need, I think is terrifying, and we have to solve this challenge together.”

Sanders also got Jorgensen to pledge to work with what are called PBMs, or companies that manage prescription drug benefits for insurance companies, employers and Medicare, to lower the price. 

Republicans were also concerned about the price of the drugs, but ranking member Senator Bill Cassidy cautioned that there’s no silver bullet to lowering healthcare costs. 

Sen. Bill Cassidy, R-LA: “so what can we do to make sure that Americans have access to an affordable cost and at the same time, we have adequate incentive so that someone out there with the incurable disease knows that there might be hope along the way.”

For more reporting from our nation’s capital, download the straight arrow news app and turn on notifications.